Literature DB >> 25176982

Survival analysis in hematologic malignancies: recommendations for clinicians.

Julio Delgado1, Arturo Pereira2, Neus Villamor3, Armando López-Guillermo4, Ciril Rozman5.   

Abstract

The widespread availability of statistical packages has undoubtedly helped hematologists worldwide in the analysis of their data, but has also led to the inappropriate use of statistical methods. In this article, we review some basic concepts of survival analysis and also make recommendations about how and when to perform each particular test using SPSS, Stata and R. In particular, we describe a simple way of defining cut-off points for continuous variables and the appropriate and inappropriate uses of the Kaplan-Meier method and Cox proportional hazard regression models. We also provide practical advice on how to check the proportional hazards assumption and briefly review the role of relative survival and multiple imputation. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Year:  2014        PMID: 25176982      PMCID: PMC4562529          DOI: 10.3324/haematol.2013.100784

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  47 in total

1.  Dealing with missing outcome data in randomized trials and observational studies.

Authors:  Rolf H H Groenwold; A Rogier T Donders; Kit C B Roes; Frank E Harrell; Karel G M Moons
Journal:  Am J Epidemiol       Date:  2011-12-23       Impact factor: 4.897

2.  Missing data in clinical studies: issues and methods.

Authors:  Joseph G Ibrahim; Haitao Chu; Ming-Hui Chen
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

Review 3.  Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation.

Authors:  Simona Iacobelli
Journal:  Bone Marrow Transplant       Date:  2013-03       Impact factor: 5.483

4.  Treatment of acute myeloid leukemia: are we making progress?

Authors:  Alan K Burnett
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

5.  Cancer statistics, 2014.

Authors:  Rebecca Siegel; Jiemin Ma; Zhaohui Zou; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-01-07       Impact factor: 508.702

Review 6.  Epidemiology of cancer-associated venous thrombosis.

Authors:  Jasmijn F Timp; Sigrid K Braekkan; Henri H Versteeg; Suzanne C Cannegieter
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

7.  Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and Meier.

Authors:  F Campigotto; D Neuberg; J I Zwicker
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

8.  Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

Authors:  Giancarlo Agnelli; Daniel J George; Ajay K Kakkar; William Fisher; Michael R Lassen; Patrick Mismetti; Patrick Mouret; Umesh Chaudhari; Francesca Lawson; Alexander G G Turpie
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

9.  Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.

Authors:  Laurent Roche; Coraline Danieli; Aurélien Belot; Pascale Grosclaude; Anne-Marie Bouvier; Michel Velten; Jean Iwaz; Laurent Remontet; Nadine Bossard
Journal:  Int J Cancer       Date:  2012-10-03       Impact factor: 7.396

10.  Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance.

Authors:  Cristina López; Julio Delgado; Dolors Costa; Neus Villamor; Alba Navarro; Maite Cazorla; Cándida Gómez; Amparo Arias; Concha Muñoz; Sandra Cabezas; Tycho Baumann; María Rozman; Marta Aymerich; Dolors Colomer; Arturo Pereira; Francesc Cobo; Armando López-Guillermo; Elías Campo; Ana Carrió
Journal:  Genes Chromosomes Cancer       Date:  2013-07-26       Impact factor: 5.006

View more
  30 in total

1.  A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe.

Authors:  Gonzalo Gutiérrez-García; Montserrat Rovira; Nacira Arab; Cristina Gallego; Joan Sánchez; María Ángeles Álvarez; Pilar Ayora; Ariadna Domenech; Nuria Borràs; Luis Gerardo Rodríguez-Lobato; Laura Rosiñol; Pedro Marín; Alexandra Pedraza; Alexandra Martínez-Roca; Esther Carcelero; María Dolores Herrera; María Teresa Solano; Carla Ramos; Noemí de Llobet; Anna Serrahima; Miquel Lozano; Joan Cid; Carmen Martínez; María Suárez-Lledó; Álvaro Urbano-Ispizua; Francesc Fernández-Avilés
Journal:  Bone Marrow Transplant       Date:  2020-01-13       Impact factor: 5.483

2.  Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.

Authors:  So-Woon Kim; Young Il Kim; Bilal Mustafa; Mi-Ju Kim; Gowun Jeong; Sung-Min Ahn; Seok-Byung Lim; Chang Sik Yu; Jin Cheon Kim; Seung-Mo Hong; In Ja Park
Journal:  Mod Pathol       Date:  2020-07-24       Impact factor: 7.842

3.  Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

Authors:  Daniel J Landsburg; Marissa K Falkiewicz; Joseph Maly; Kristie A Blum; Christina Howlett; Tatyana Feldman; Anthony R Mato; Brian T Hill; Shaoying Li; L Jeffrey Medeiros; Pallawi Torka; Francisco Hernandez-Ilizaliturri; Nishitha M Reddy; Arun Singavi; Timothy S Fenske; Julio C Chavez; Jason B Kaplan; Amir Behdad; Adam M Petrich; Martin A Bast; Julie M Vose; Adam J Olszewski; Cristiana Costa; Frederick Lansigan; James N Gerson; Stefan K Barta; Oscar Calzada; Jonathon B Cohen; Jennifer K Lue; Jennifer E Amengual; Xavier Rivera; Daniel O Persky; David J Peace; Sunita Nathan; Ryan D Cassaday
Journal:  J Clin Oncol       Date:  2017-05-05       Impact factor: 44.544

4.  Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing.

Authors:  Jae-Sook Ahn; TaeHyung Kim; Sung-Hoon Jung; Seo-Yeon Ahn; Seung-Yeon Jung; Ga-Young Song; Mihee Kim; Deok-Hwan Yang; Je-Jung Lee; SeungHyun Choi; Ja-Yeon Lee; Seong-Kyu Park; Joon Ho Moon; Hui Young Lee; Kyoung Ha Kim; Yu Cai; Seong Yoon Yi; Igor Novitzky-Basso; Zhaolei Zhang; Hyeoung-Joon Kim; Dennis Dong Hwan Kim
Journal:  Bone Marrow Transplant       Date:  2020-12-05       Impact factor: 5.483

5.  Fludarabine, High Dose Cytarabine and Granulocyte Colony-Stimulating Factor (FLAG) as Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia: A Retrospective Cohort Study.

Authors:  Kian Boon Law; Kian Meng Chang; Nor Aishah Hamzah; Kok Haur Ng; Tee Chuan Ong
Journal:  Indian J Hematol Blood Transfus       Date:  2017-02-14       Impact factor: 0.900

6.  Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma.

Authors:  S A Graf; P A Stevenson; L A Holmberg; B G Till; O W Press; T R Chauncey; S D Smith; M Philip; J J Orozco; A R Shustov; D J Green; E N Libby; W I Bensinger; J M Pagel; D G Maloney; Y Zhou; R D Cassaday; A K Gopal
Journal:  Ann Oncol       Date:  2015-09-07       Impact factor: 32.976

7.  Impact of somatic and germline mutations on the outcome of systemic mastocytosis.

Authors:  Javier I Muñoz-González; María Jara-Acevedo; Iván Alvarez-Twose; Jason D Merker; Cristina Teodosio; Yanli Hou; Ana Henriques; Krishna M Roskin; Laura Sanchez-Muñoz; Albert G Tsai; Carolina Caldas; Almudena Matito; J Ignacio Sánchez-Gallego; Andrea Mayado; Noelia Dasilva-Freire; Jason R Gotlib; Luis Escribano; Alberto Orfao; Andrés C García-Montero
Journal:  Blood Adv       Date:  2018-11-13

8.  Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.

Authors:  Ferran Nadeu; Julio Delgado; Cristina Royo; Tycho Baumann; Tatjana Stankovic; Magda Pinyol; Pedro Jares; Alba Navarro; David Martín-García; Sílvia Beà; Itziar Salaverria; Ceri Oldreive; Marta Aymerich; Helena Suárez-Cisneros; Maria Rozman; Neus Villamor; Dolors Colomer; Armando López-Guillermo; Marcos González; Miguel Alcoceba; Maria José Terol; Enrique Colado; Xose S Puente; Carlos López-Otín; Anna Enjuanes; Elías Campo
Journal:  Blood       Date:  2016-02-02       Impact factor: 22.113

9.  Preoperative high-sensitivity troponin I and B-type natriuretic peptide, alone and in combination, for risk stratification of mortality after liver transplantation.

Authors:  Young-Jin Moon; Hye-Mee Kwon; Kyeo-Woon Jung; Kyoung-Sun Kim; Won-Jung Shin; In-Gu Jun; Jun-Gol Song; Gyu-Sam Hwang
Journal:  Korean J Anesthesiol       Date:  2020-08-26

10.  An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures.

Authors:  Yang Yang; Yu Han; Xintao Hu; Wen Wang; Guangbin Cui; Lei Guo; Xin Zhang
Journal:  Front Neurosci       Date:  2021-05-13       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.